Withdrawal: MiR-181a regulates CD4+ T cell activation and differentiation by targeting IL-2 in the pathogenesis of myasthenia gravis

Xiaofang Liu, Mengchuan Luo, Huanyu Meng, Qiuming Zeng, Liqun Xu, Bo Hu, Yuebei Luo, Chang Liu, Zhaohui Luo and Huan Yang

The above article, published as accepted article online on 26 July 2019 in Wiley Online Library (https://onlinelibrary.wiley.com/doi/10.1002/eji.201848007) has been withdrawn by agreement between authors, the journal's Editor in Chief, Chiara Romagnani, and Wiley-VCH GmbH. The withdrawal has been agreed following a detailed investigation based on concerns raised by a third party. Multiple flaws and inconsistencies between the results presented and the experimental methods described were found and the editors consider the conclusions of this article to be invalid.

撤回：MiR-181a 在重症肌无力发病机制中通过靶向 IL-2 调节 CD4+ T 细胞活化和分化

刘晓芳、罗孟川、孟焕宇、曾秋明、徐立群、胡波、罗月贝、刘畅、罗兆辉、杨欢

上述文章于 2019 年 7 月 26 日在 Wiley 在线图书馆 (https://onlinelibrary.wiley.com/doi/10.1002/eji.201848007) 在线发表为已接受文章，经作者、该期刊主编同意撤回， Chiara Romagnani 和 Wiley-VCH GmbH。根据第三方提出的担忧进行详细调查后，同意撤回。发现所提供的结果与所描述的实验方法之间存在多个缺陷和不一致，编辑认为本文的结论是无效的。